Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-06-01 00:00:00 ET · period of report 2023-05-30 · accession 0001209191-23-033321 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-01 | 2023-05-30 | VRTX | Arbuckle Stuart A | EVP, COO | S - Sale | $329.82 | -82 | 56.6K | -0.1% | -$27.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-30 | S | D | 82 | $329.82 | 56,556 | D | — | — |